Basic fibroblast growth factor induces down‐regulation of α‐smooth muscle actin and reduction of myofibroblast areas in open skin wounds
- 6 July 2009
- journal article
- Published by Wiley in Wound Repair and Regeneration
- Vol. 17 (4), 617-625
- https://doi.org/10.1111/j.1524-475x.2009.00511.x
Abstract
To examine the effects of basic fibroblast growth factor (bFGF) on the inhibition of α‐smooth muscle actin (α‐SMA) expression in dermal fibroblasts, we have established two dermal myofibroblastic cell lines positive for α‐SMA (rat myofibroblasts [RMF] and rat myofibroblast‐like [RMFL] cells) and one fibroblastic cell line negative for α‐SMA (rat fibroblasts cells) as a model of fibroblast differentiation. In contrast to the increased expression of α‐SMA in RMF and RMFL cells, irrespective of transforming growth factor‐β1 treatment, bFGF induced a decrease in α‐SMA expression in the myofibroblastic cells and the reduced expression patterns of α‐SMA differed between cells, as demonstrated by Western blot and reverse transcription polymerase chain reaction analyses. Along with the inhibition of α‐SMA expression by bFGF, the RMF and RMFL cells also showed different activated expression of extracellular signal‐regulated kinase 1/2, suggesting the involvement of extracellular signal‐regulated kinase 1/2 activation in the down‐regulation of α‐SMA expression in myofibroblasts. Furthermore, an in vivo study demonstrated that bFGF administration markedly decreases the area that is positive for α‐SMA expression in the treated wounds after day 18. In contrast, bFGF administration significantly increased the number of terminal deoxynucleotidyl transferase (TdT)‐mediated dUTP nick‐end labeling (TUNEL) staining and α‐SMA‐positive cells at days 10 and 14, and reduced the double‐positive cells rapidly after day 18. Collectively, the current investigation identified bFGF as a potent stimulator for the reduction of the myofibroblastic area in vivo, presumably because of its effects on the down‐regulation of α‐SMA expression as well as rapid induction of apoptosis in myofibroblasts.Keywords
This publication has 35 references indexed in Scilit:
- Focal Adhesion Kinase (FAK)-related Non-kinase Inhibits Myofibroblast Differentiation through Differential MAPK Activation in a FAK-dependent MannerJournal of Biological Chemistry, 2008
- Heparan sulfate–dependent ERK activation contributes to the overexpression of fibrotic proteins and enhanced contraction by scleroderma fibroblastsArthritis & Rheumatism, 2008
- Basic fibroblast growth factor in an artificial dermis promotes apoptosis and inhibits expression of α‐smooth muscle actin, leading to reduction of wound contractionWound Repair and Regeneration, 2007
- Combinatorial activation of FAK and AKT by transforming growth factor-β1 confers an anoikis-resistant phenotype to myofibroblastsCellular Signalling, 2007
- Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGF-mediated promotion of neural stem cell proliferationCell Research, 2007
- Basic Fibroblast Growth Factor Activates ERK and Induces c-Fos in Human Embryonic Stem Cell Line MizhES1Stem Cells and Development, 2005
- Smad3 and Extracellular Signal-Regulated Kinase 1/2 Coordinately Mediate Transforming Growth Factor-β-Induced Expression of Connective Tissue Growth Factor in Human FibroblastsJournal of Investigative Dermatology, 2005
- Perspective Article: Tissue repair, contraction, and the myofibroblastWound Repair and Regeneration, 2005
- Extracellular Signal-Regulated Kinases Regulate Dendritic Growth in Rat Sympathetic NeuronsJournal of Neuroscience, 2004
- A mechanism of repression of TGFbeta / Smad signaling by oncogenic RasGenes & Development, 1999